526 related articles for article (PubMed ID: 25454992)
1. Screening, prevention, and treatment of congenital cytomegalovirus.
Johnson J; Anderson B
Obstet Gynecol Clin North Am; 2014 Dec; 41(4):593-9. PubMed ID: 25454992
[TBL] [Abstract][Full Text] [Related]
2. Passive immunization during pregnancy for congenital cytomegalovirus infection.
Nigro G; Adler SP; La Torre R; Best AM;
N Engl J Med; 2005 Sep; 353(13):1350-62. PubMed ID: 16192480
[TBL] [Abstract][Full Text] [Related]
3. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.
Nigro G
Expert Rev Anti Infect Ther; 2017 Nov; 15(11):977-986. PubMed ID: 29072089
[TBL] [Abstract][Full Text] [Related]
4. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy.
Yinon Y; Farine D; Yudin MH
Obstet Gynecol Surv; 2010 Nov; 65(11):736-43. PubMed ID: 21375790
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and antenatal management of congenital cytomegalovirus infection.
; Hughes BL; Gyamfi-Bannerman C
Am J Obstet Gynecol; 2016 Jun; 214(6):B5-B11. PubMed ID: 26902990
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
Blázquez-Gamero D; Galindo Izquierdo A; Del Rosal T; Baquero-Artigao F; Izquierdo Méndez N; Soriano-Ramos M; Rojo Conejo P; González-Tomé MI; García-Burguillo A; Pérez Pérez N; Sánchez V; Ramos-Amador JT; De la Calle M
J Matern Fetal Neonatal Med; 2019 Feb; 32(4):617-625. PubMed ID: 28978246
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus: should we screen pregnant women for primary infection?
Johnson JM; Anderson BL
Am J Perinatol; 2013 Feb; 30(2):121-4. PubMed ID: 23292913
[TBL] [Abstract][Full Text] [Related]
8. No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: experience from a single centre.
Chiaie LD; Neuberger P; Vochem M; Lihs A; Karck U; Enders M
Arch Gynecol Obstet; 2018 Jun; 297(6):1389-1395. PubMed ID: 29404743
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
Revello MG; Lazzarotto T; Guerra B; Spinillo A; Ferrazzi E; Kustermann A; Guaschino S; Vergani P; Todros T; Frusca T; Arossa A; Furione M; Rognoni V; Rizzo N; Gabrielli L; Klersy C; Gerna G;
N Engl J Med; 2014 Apr; 370(14):1316-26. PubMed ID: 24693891
[TBL] [Abstract][Full Text] [Related]
10. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
Seidel V; Hackelöer M; Rancourt RC; Henrich W; Siedentopf JP
Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
[TBL] [Abstract][Full Text] [Related]
11. Findings and conclusions from CMV hyperimmune globulin treatment trials.
Adler SP; Nigro G
J Clin Virol; 2009 Dec; 46 Suppl 4():S54-7. PubMed ID: 19781985
[TBL] [Abstract][Full Text] [Related]
12. Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention.
Naing ZW; Scott GM; Shand A; Hamilton ST; van Zuylen WJ; Basha J; Hall B; Craig ME; Rawlinson WD
Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):9-18. PubMed ID: 26391432
[TBL] [Abstract][Full Text] [Related]
13. New advances in the diagnosis of congenital cytomegalovirus infection.
Lazzarotto T; Guerra B; Lanari M; Gabrielli L; Landini MP
J Clin Virol; 2008 Mar; 41(3):192-7. PubMed ID: 18054840
[TBL] [Abstract][Full Text] [Related]
14. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.
Buxmann H; Stackelberg OM; Schlößer RL; Enders G; Gonser M; Meyer-Wittkopf M; Hamprecht K; Enders M
J Perinat Med; 2012 Mar; 40(4):439-46. PubMed ID: 22752777
[TBL] [Abstract][Full Text] [Related]
15. [Congenital cytomegalovirus infection--clinical characteristics including prenatal diagnosis].
Milewska-Bobula B
Med Wieku Rozwoj; 2003; 7(3 Suppl 1):123-7. PubMed ID: 15537252
[TBL] [Abstract][Full Text] [Related]
16. [Significance of diagnostics and treatment in preventing congenital infections with Toxoplasma gondii (Tg), cytomegalovirus (CMV) and parvowirus B19 (PVB19)].
Szenborn L
Przegl Lek; 2010; 67(1):54-7. PubMed ID: 20509575
[TBL] [Abstract][Full Text] [Related]
17. Prevention of maternal-fetal transmission of cytomegalovirus.
Adler SP; Nigro G
Clin Infect Dis; 2013 Dec; 57 Suppl 4():S189-92. PubMed ID: 24257425
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus Screening in Pregnancy: A Cost-Effectiveness and Threshold Analysis.
Albright CM; Werner EF; Hughes BL
Am J Perinatol; 2019 Jun; 36(7):678-687. PubMed ID: 30567003
[TBL] [Abstract][Full Text] [Related]
19. [Congenital cytomegaly--advances in diagnosis and therapy].
Milewska-Bobula B; Lipka B
Przegl Epidemiol; 2009; 63(1):79-83. PubMed ID: 19522232
[TBL] [Abstract][Full Text] [Related]
20. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.
Hamilton ST; van Zuylen W; Shand A; Scott GM; Naing Z; Hall B; Craig ME; Rawlinson WD
Rev Med Virol; 2014 Nov; 24(6):420-33. PubMed ID: 25316174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]